Thuluva S, Paradkar V, Gunneri S, Yerroju V, et al. Safety, tolerability and immunogenicity of Biological E's CORBEVAX vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study. Vaccine 2022 Oct 31. pii: S0264-410X(22)01308.
PMID: 36328879